Synergy CHC Corp. SNYR
Nasdaq · stock · Medicinal Chemicals & Botanical Products · website · IPO 2013-11-08
Synergy CHC Corp. statistics & valuation
Market cap$3.1M
P / S0.1×
Net margin-40.6%
Net debt$22.4M
Enterprise value USD$25.6M
Earnings yield EBIT/EV-33.1%
Return on capital-438.7%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 66.8% | 67.9% | 75.0% | 68.9% | 67.4% | 72.4% | 70.7% | 60.6% | 38.7% | — |
| Operating margin | -27.8% | 16.7% | 25.3% | -27.1% | -14.5% | 5.1% | 8.4% | 3.6% | -10461.8% | — |
| Net margin | -40.6% | 6.1% | 14.8% | -31.4% | -18.2% | 1.4% | -2.3% | -56.0% | -10483.6% | — |
| FCF margin | — | — | — | — | 3.5% | -2.8% | 16.5% | -4.8% | — | — |
| Return on assets | -121.4% | 13.0% | 51.8% | -177.4% | -30.8% | 2.1% | -3.9% | -28.2% | -1733.8% | -2907.4% |
| Return on equity | 53.4% | -12.8% | -23.2% | 177.0% | -155.2% | 5.3% | -11.2% | -139.1% | 764.0% | 511.1% |
| Debt / equity | -1.08× | -0.45× | -0.48× | — | — | — | — | — | — | — |
| Current ratio | 1.22 | 0.93 | 0.84 | 0.50 | 0.86 | 1.46 | 0.60 | 0.61 | 0.31 | — |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.